BA
CVS icon

Boston Advisors’s CVS Health CVS Stock Holding History

Boston Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3.27M Buy
51,860
+2,492
+5% +$148K 0.17% 157
2019
Q2 		$2.69M Sell
49,368
-98,226
-67% -$5.29M 0.14% 185
2019
Q1 		$7.96M Sell
147,594
-88,881
-38% -$5.49M 0.41% 59
2018
Q4 		$15.5M Buy
236,475
+33,696
+17% +$2.52M 0.9% 15
2018
Q3 		$16M Sell
202,779
-211,898
-51% -$15.1M 0.69% 18
2018
Q2 		$26.7M Buy
414,677
+28,756
+7% +$1.9M 0.67% 30
2018
Q1 		$24M Buy
385,921
+345,683
+859% +$24.8M 0.62% 36
2017
Q4 		$2.92M Sell
40,238
-118,222
-75% -$8.6M 0.06% 261
2017
Q3 		$12.9M Sell
158,460
-248,340
-61% -$19.6M 0.29% 106
2017
Q2 		$32.7M Sell
406,800
-65,988
-14% -$5.21M 0.76% 21
2017
Q1 		$37.1M Buy
472,788
+90,977
+24% +$7.26M 0.87% 16
2016
Q4 		$30.1M Sell
381,811
-63,819
-14% -$5.16M 0.72% 24
2016
Q3 		$39.7M Sell
445,630
-533
-0.1% -$50.3K 0.98% 13
2016
Q2 		$42.7M Buy
446,163
+28,096
+7% +$2.8M 1.07% 12
2016
Q1 		$43.4M Buy
418,067
+19,428
+5% +$1.89M 1.07% 14
2015
Q4 		$39M Buy
398,639
+287,504
+259% +$28.2M 0.91% 22
2015
Q3 		$10.7M Buy
111,135
+16,527
+17% +$1.74M 0.4% 68
2015
Q2 		$9.92M Sell
94,608
-2,877
-3% -$294K 0.41% 77
2015
Q1 		$10.1M Sell
97,485
-7,744
-7% -$784K 0.4% 81
2014
Q4 		$10.1M Sell
105,229
-5,862
-5% -$517K 0.43% 78
2014
Q3 		$8.84M Buy
111,091
+24,016
+28% +$1.89M 0.38% 97
2014
Q2 		$6.56M Sell
87,075
-35,069
-29% -$2.65M 0.28% 105
2014
Q1 		$9.14M Buy
122,144
+28,862
+31% +$2.04M 0.41% 79
2013
Q4 		$6.68M Buy
93,282
+5,599
+6% +$360K 0.32% 98
2013
Q3 		$4.98M Sell
87,683
-463
-0.5% -$27.6K 0.26% 103
2013
Q2 		$5.04M Buy
+88,146
New +$5.11M 0.24% 103

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Advisors's CVS Position: Q3 2019 in Review

Boston Advisors increased its CVS Health (CVS) stake by 5% in Q3 2019, buying an estimated $148K and bringing the position to 51,860 shares worth $3.27M. The position accounts for 0.17% of the portfolio, ranked #157.

Boston Advisors first reported a position in CVS in Q2 2013 and has held it in 26 quarters since. The position peaked at $43.4M in Q1 2016. 1,684 funds tracked by Wall St. Rank hold CVS as of Q3 2019.

  • Boston Advisors held 51,860 shares of CVS Health worth $3.27M as of Q3 2019.
  • Boston Advisors bought 2,492 CVS Health shares in Q3 2019, an estimated $148K.
  • CVS Health made up 0.17% of Boston Advisors's portfolio in Q3 2019, its #157 holding.
  • Boston Advisors first reported a position in CVS Health in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's CVS Health position peaked at $43.4M in Q1 2016.
  • 1,684 funds tracked by Wall St. Rank held CVS Health as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.